Fibrinogen: Optimization of Therapeutic Apheresis Variables

Overview

About this study

The purpose of this study is to determine intra and post-plasma exchange fibrinogen levels using 3 different replacement strategies  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • All patients undergoing plasma exchange using either 100% albumin, 50% albumin and 50% plasma, or 100% plasma will be eligible for participation in this study. 

Exclusion Criteria: 

  • Major exclusions include pregnant women, prisoners, and patients under the age of 18 years old. 

Eligibility last updated 7/29/22. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Lawrence Williams, M.D.

Open for enrollment

Contact information:

Lawrence Williams M.D.

(480) 342-5890

Williams.Lawrence@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20553552

Mayo Clinic Footer